Our case was thought to be in favor of myeloid sarcoma, since MPO-, CD34-, CD117-, HLA-DR-, and LCA-positive immunoreactivity was detected in the tru-cut biopsy specimens performed from lesions showing FDG uptake in bilateral breasts and axillae. This evidence concerns the gene KIT and myeloid sarcoma.